Prenetics Global Ltd. engages in the development of genomics-driven health sciences that seek early detection, prevention, and treatment of cancer. The firm offers products and services under the brands of CircleDNA, Insighta, and ACT Genomics. It operates through the Prevention and Diagnostics segments. The Prevention segment refers to the design and sale of genetics testing and stool-based DNA test for early colorectal cancer screening. The Diagnostic segment focuses on the sale of precision oncology testing services. The company was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and is headquartered in Hong Kong.